Novel assay for Roberts syndrome assigns variable phenotypes to one complementation group.

Area of Science:

• Genetics
• Cell Biology
• Developmental Biology

Background:

• Roberts syndrome (RS) is a rare autosomal recessive disorder with diverse clinical manifestations, including tetraphocomelia, cleft lip, and cleft palate.
• RS cells display characteristic cytogenetic abnormalities, notably heterochromatic splaying, which is the premature separation of heterochromatin regions on metaphase chromosomes.

Observation:

• A new RS patient with a severe phenotype was identified, and a permanent cell line was established.
• A novel in vitro complementation assay was developed for rapid evaluation of genetic complementation in RS cells.

Findings:

• Somatic cell hybridization experiments confirmed that the new RS patient's cells could be complemented by control cells.
• The new patient was assigned to the same genetic complementation group as previously studied RS patients, irrespective of clinical severity.

Implications:

• This research consolidates the genetic understanding of Roberts syndrome, indicating a single etiological basis for the observed heterochromatic splaying.
• The findings suggest that clinical variability in RS may not stem from distinct genetic complementation groups but potentially from other genetic or environmental factors.
• The established cell line and assay provide valuable tools for future research into the molecular mechanisms underlying Roberts syndrome and heterochromatin regulation.